Previous 10 | Next 10 |
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
- Aptima® SARS-CoV-2/Flu Assay Tests Simultaneously for SARS-CoV-2, Influenza A and B on Fully Automated Panther® Molecular Diagnostics System - Hologic, Inc. (Nasdaq: HOLX) announced today that its Aptima ® SARS-CoV-2/Flu Assay is now available for the si...
Global leader in women’s health partners with medical streaming platform, Mediflix, to provide first-of-its-kind awareness and education tool highlighting reconstructive options for breast cancer patients In conjunction with ongoing Breast Cancer Awareness Month effor...
Black Women’s Health Imperative and Hologic hosted Unmuting Fibroids: Getting Loud for Equal Care - A Roundtable to Address Disparities in Uterine Fibroid Care A multidisciplinary group of experts agree that elevating awareness of a woman’s period as a vita...
A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. Focus on IBB. A list of cheap stocks. For further details see: IBB: Healthcare Dashboard For October
-- Transaction Further Diversifies Hologic’s Product Offering and Broadens Access to Bolder Devices -- Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has signed a definitive agreement to acquire Bolder Surgical, a privately he...
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the fourth quarter of fiscal 2021 on Monday, November 1, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Easter...
Launch brings Novodiag’s benefits to broader range of European customers and expands Hologic’s offering of world-leading molecular scalable solutions Hologic, Inc. (Nasdaq: HOLX) today announced its broad European launch of the Novodiag ® system, a ful...
Leader in women’s health launches series of educational and awareness initiatives focused on eliminating racial disparities in breast cancer screening and care Hologic, Inc. (Nasdaq: HOLX), an innovative medical technology company primarily focused on improving women&...
New Omni 30° hysteroscope, Omni Lok cervical seal and Omni 5 French seal provide increased flexibility to support physicians both diagnosing and treating patients Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, has launched its expanded Omni ® ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-30 10:30:04 ET BTIG analyst issues NEUTRAL recommendation for HOLX on July 30, 2024 08:28AM ET. The previous analyst recommendation was Neutral. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current an...
2024-07-30 09:30:03 ET RBC Capital analyst issues SECTOR PERFORM recommendation for HOLX on July 30, 2024 07:43AM ET. The previous analyst recommendation was Sector Perform. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus ...
– Revenue of $1,011.4 Million, GAAP Diluted EPS of $0.82, and Non-GAAP Diluted EPS of $1.06; All Met or Exceeded Guidance – – Total Company Revenue Growth of 2.7%, or 3.1% in Constant Currency and 5.8% Organically excluding COVID-19; Against Growth of 18.4% in the Prior Y...